Deciphera Pharmaceuticals CEO Steven Hoerter receives $9M in 2019
Deciphera Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
Deciphera Pharmaceuticals reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, five executives at Deciphera Pharmaceuticals received on average a compensation package of $4.7M, a 32% increase compared to previous year.
Average pay of disclosed executives at Deciphera Pharmaceuticals
Steven L. Hoerter, Chief Executive Officer, received $9M in total. 75% of Hoerter's compensation, or $6.8M, was in option awards. Hoerter also received $479K in non-equity incentive plan, $450K in salary, as well as $1.3M in stock awards.
Michael D. Taylor, Chief Executive Officer, received a compensation package of $5.2M, which decreased by 1% compared to previous year. 89% of the compensation package, or $4.6M, was in option awards.
Matthew L. Sherman, Chief Medical Officer, earned $5.1M in 2019.
Thomas P. Kelly, Chief Financial Officer, received $2.1M in 2019, which decreases by 10% compared to 2018.
Daniel C. Martin, Chief Commercial Officer, earned $2.1M in 2019, a 34% decrease compared to previous year.
Related executives
Steven Hoerter
Deciphera Pharmaceuticals
Chief Executive Officer
Michael Taylor
Deciphera Pharmaceuticals
Chief Executive Officer
Thomas Kelly
Deciphera Pharmaceuticals
Chief Financial Officer
Matthew Sherman
Deciphera Pharmaceuticals
Chief Medical Officer
Daniel Martin
Deciphera Pharmaceuticals
Chief Commercial Officer
You may also like
Source: SEC filing on April 24, 2020.